Valeant to Buy Medicis Pharmaceutical in $2.6 Billion Deal

Valeant Pharmaceuticals International, Inc. said it agreed to buy Medicis Pharmaceutical Corp. in a transaction valued at about $2.6 billion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.